Marc Symons

Feinstein Institute for Medical Research — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

59h-index15.2kcitations255works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(62), Cellular Mechanics and Interactions(35), Glioma Diagnosis and Treatment(27), Cell Adhesion Molecules Research(26), Cancer Mechanisms and Therapy(22)

Publications254 total

Supplementary Figure S2 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S1 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Data from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure 6 from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Supplementary Figure 5 from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Supplementary Figure S1 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure S4 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Data from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure 2 from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Figure S1 from Gefitinib Inhibits Invasion and Metastasis of Osteosarcoma via Inhibition of Macrophage Receptor Interacting Serine-Threonine Kinase 2
2023Open Access
Data from Gefitinib Inhibits Invasion and Metastasis of Osteosarcoma via Inhibition of Macrophage Receptor Interacting Serine-Threonine Kinase 2
2023Open Access
Supplementary Figure 4 from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Data from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Figure S2 from Gefitinib Inhibits Invasion and Metastasis of Osteosarcoma via Inhibition of Macrophage Receptor Interacting Serine-Threonine Kinase 2
2023Open Access
Supplementary Figure S2 from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figures Legends from Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
2023Open Access
Supplementary Figure 4 from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Data from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Supplementary Figure 3 from SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide
2023Open Access
Figure S1 from Gefitinib Inhibits Invasion and Metastasis of Osteosarcoma via Inhibition of Macrophage Receptor Interacting Serine-Threonine Kinase 2
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Rongguo Qiu(7), Frank McCormick(7), Channing J. Der(7), Salvatore J. Coniglio(5), Richard G. Pestell(5), Nhan L. Tran(5), Amanda Chan(5), Rosamaria Ruggieri(4), Mitsutoshi Nakada(4), Michael E. Berens(4), John Westwick(3), John H. Exton(3), Nicole Rusk(3), David Stokoe(2), Susan G. Macdonald(2), Arie Abo(2), Mike Lorenz(2), Jeffrey E. Segall(2), John S. Condeelis(2), Rongyan Qiu(2)